NASDAQ · Financial Statements

Yarrow Bioscience, Inc. (YARW) Financial Statements

$20.33 NASDAQ: YARW Market Cap $189.16M

Yarrow Bioscience, Inc. most recently reported annual revenue of $1.0M, net profit of $-26.0M, revenue has compounded at -45.6% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$0$0$1.0M$1.0M
Operating Profit$-39.0M$-34.0M$-29.0M$-44.0M$-30.0M
Net Profit$-73.0M$-23.0M$-28.0M$-40.0M$-26.0M
EPS$-1282.44$-566.98$-138.48$-46.77$-30.96
Op Margin-4179.5%-7189.7%-6900.5%-8710.0%-5219.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$67.0M$41.0M$98.0M$67.0M$30.0M
Total Liabilities$18.0M$10.0M$9.0M$15.0M$2.0M
Cash$42.0M$31.0M$31.0M$20.0M$24.0M
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-56.0M$-29.0M$-25.0M$-34.0M$-33.0M
Investing Cash Flow$1.0M$16.0M$-57.0M$23.0M$37.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-16.0M$-12.0M$0$-11.0M$4.0M
Free Cash Flow$-56.0M$-29.0M$-25.0M$-34.0M$-33.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-8.81
FCF Yield-8.97%
Quick Ratio15.26
Interest Coverage0.00
Return 1Y179.45%
Return 3Y-76.08%
Return 5Y-97.71%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
YARW Overview YARW Dividend Run Stock Screener